Novel therapeutic agents for HbF induction: a new era for treatment of β thalassemia?
<p>Fetal globin is endogenous, normally integrated in hematopoietic stem cells in all humans, and available for reactivation. Inducing expression of fetal globin (g-globin) gene expression to 60-70% of a globin synthesis produces β-thalassemia trait globin synthetic ratios, and has be...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-12-01
|
Series: | Thalassemia Reports |
Subjects: | |
Online Access: | http://www.pagepressjournals.org/index.php/thal/article/view/297 |